RecruitingPhase 3NCT04381936
Randomised Evaluation of COVID-19 Therapy
Studying Severe acute respiratory syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Oxford
- Principal Investigator
- Peter W HorbyUniversity of Oxford
- Intervention
- Lopinavir-Ritonavir(drug)
- Enrollment
- 70000 target
- Eligibility
- 0 years · All sexes
- Timeline
- 2020 – 2036
Study locations (7)
- Kumasi Center for Collaborative Research in Tropical Medicine KNUST, Kumasi, Ghana
- Indian Council of Medical Research, Division of Epidemiology and Communicable Diseases, New Delhi, India
- Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta, Indonesia
- Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal
- Wits Health Consortium, Johannesburg, South Africa
- Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
- Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam
Collaborators
UK Research and Innovation · National Institute for Health Research, United Kingdom · Wellcome Trust · Bill and Melinda Gates Foundation · Department for International Development, United Kingdom · Health Data Research UK · Medical Research Council Population Health Research Unit · NIHR Health Protection Research Unit in Emerging and Zoonotic Infections · Flu Lab
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04381936 on ClinicalTrials.govOther trials for Severe acute respiratory syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2Centre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE4NCT06585241A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsModernaTX, Inc.
- RECRUITINGNCT06168019Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaBoston University
- RECRUITINGEARLY PHASE1NCT05656105Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionUniversity of Alabama at Birmingham
- RECRUITINGNCT05892549COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern CharacteristicsDirection Centrale du Service de Santé des Armées
- RECRUITINGNANCT05566483Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional CapacityUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGNCT05787964Immunity to Infection in Healthy Participants and Participants With CancerUniversity Hospital Tuebingen
- RECRUITINGPHASE2, PHASE3NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenBioNTech SE